Table 2.
Comparison of primary and secondary health outcomes before and after the 8-week intervention in patients with hypertension.
| Outcome | Intervention group (n=31) |
Control group (n=31) |
Between-group difference at 8 weeks | P valuea | ||||
|
|
Before (week 0) | After (week 8) | Before (week 0) | After (week 8) | Adjusted mean difference (95% CI) |
|
||
| 6MWDb (m), mean (SD) | 472.05 (79.58) | 528 (69.54) | 448.57 (138.53) | 449.43 (94.60) | 62.77 (26.33-99.22) | .002 c | ||
| IPAQd (METe-min/week), median (IQR) | 1386 (510-2190) | 1983 (1597.25-3037.50) | 897 (636-1386) | 1464 (1016.7-51924.50) | 658.96 (159.23-1158.69) | .01 | ||
| PHQ-9f, mean (SD) | 6.03 (3.91) | 2.72 (3.31) | 5.13 (4.49) | 2.75 (1.82) | –0.14 (–1.64 to 1.36) | .85 | ||
| GAD-7g, mean (SD) | 6.23 (4.38) | 2.41 (2.20) | 4.48 (4.21) | 2.25 (1.68) | –0.23 (–1.26 to 0.80) | .65 | ||
| SF-12h, mean (SD) |
|
|
|
|
|
|
||
| PCSi, mean (SD) | 41.38 (6.86) | 47.51 (6.12) | 42.64 (9.06) | 47.26 (6.65) | 0.66 (–2.64 to 3.96) | .69 | ||
| MCSj, mean (SD) | 46.28 (10.17) | 54.37 (5.20) | 46.34 (10.16) | 54.18 (5.04) | 0.19 (–2.68 to 3.07) | .89 | ||
| Exercise self-efficacy, mean (SD) | 52.96 (30.02) | 84.23 (15.84) | 60.93 (28.37) | 62.85 (12.67) | 21.71 (13.59-29.82) | ＜.001 | ||
| Weight (kg), mean (SD) | 64.53 (11.57) | 63.92 (11.04) | 66.32 (14.54) | 66.66 (14.27) | –1.02 (–1.96 to 0.08) | .053 | ||
| Girth (cm) | 86.68 (9.76) | 86.84 (9.80) | 88.03 (9.31) | 88 (9.40) | 0.12 (–1.54 to 1.78) | .88 | ||
| Hipline (cm) | 97 (8.03) | 96.48 (7.61) | 98.45 (8.16) | 97.71 (8.43) | –0.06 (–2.49 to 2.37) | .96 | ||
| Right grip strength (kg), mean (SD) | 32.87 (10.68) | 35.89 (11.23) | 26.49 (6.25) | 27.70 (8.81) | 4.39 (–4.67 to 13.44) | .33 | ||
| Left grip strength (kg), mean (SD) | 29.68 (10.16) | 34 (11.24) | 25.71 (6.27) | 26.73 (9.71) | 4.85 (–3.68 to 13.38) | .25 | ||
| Systolic BPk (mm/Hg) | 128.30 (9.28) | 116.63 (7.64) | 129.96 (15.21) | 120.92 (7.15) | 4.11 (0.11-8.28) | .046 | ||
| Diastolic BP (mm/Hg) | 84.52 (8.24) | 75.56 (8.79) | 85.25 (9.29) | 77.71 (9.16) | 1.81 (–2.72 to 6.35) | .43 | ||
aThe significance level was set at P<.05.
b6MWD: 6-minute walk distance.
cThe italicized values are the P value of the primary outcome.
dIPAQ: International Physical Activity Questionnaire.
eMET: metabolic equivalent of task.
fPHQ-9: Patient Health Questionnaire-9.
gGAD-7: Generalized Anxiety Disorder-7.
hSF-12: Short-Form Health Survey 12.
iPCS: Physical Component Summary.
jMCS: Mental Component Summary.
kBP: blood pressure.